|
|
||||||||
,




,
,
,
,¶
,
* Institut National de la Santé et de la Recherche Médicale, U662, Paris, France;
Université Paris 7, Institut Universitaire dHématologie, Paris, France;
Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Centre dInvestigations Biomédicales "Hématologie Oncologie Greffe", Paris, France;
Institut National de la Santé et de la Recherche Médicale U728, Paris, France;
¶ Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Service dHématologie-Greffe de Moelle, Paris, France;
|| Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Service de Virologie, Paris, France;
# Cytokine and Lymphoid Development Unit, Institut Pasteur, Paris, France; and
** Institut National de la Santé et de la Recherche Médicale U668, Paris, France
The expansion of the cytokine-producing CD56bright NK cell subset is a main feature of lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT). We investigated phenotypes and functions of CD56bright and CD56dim NK subsets from 43 HLA-matched non-T cell-depleted HSCT donor-recipient pairs. The early expansion of CD56bright NK cells gradually declined in the posttransplant period but still persisted for at least 1 year and was characterized by the emergence of an unusual CD56brightCD16low subset with an intermediate maturation profile. The activating receptors NKG2D and NKp46, but also the inhibitory receptor NKG2A, were overexpressed compared with donor CD56bright populations. Recipient CD56bright NK cells produced higher amounts of IFN-
than did their respective donors and were competent for degranulation. Intracellular perforin content was increased in CD56bright NK cells as well as in T cells compared with donors. IL-15, the levels of which were increased in the posttranplant period, is a major candidate to mediate these changes. IL-15 serum levels and intracellular T cell perforin were significantly higher in recipients with acute graft-vs-host disease. Altogether, CD56bright NK cells postallogeneic HSCT exhibit peculiar phenotypic and functional properties. Functional interactions between this subset and T cells may be important in shaping the immune response after HSCT.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by research grants from the Association de Recherche contre le Cancer (N.D.), Fondation pour la Recherche Médicale (fellowship DEA20040902110 to P.H.), Association Laurette Fugain, Cancéropôle Ile-de-France, and EC program FP6 ALLOSTEM (no. 503319).
2 N.D. and P.H. contributed equally to this work.
3 Address correspondence and reprint requests to Dr. Nicolas Dulphy, Unité Institut National de la Santé et de la Recherche Médicale U662, Centre Hayem, Institut Universitaire dHématologie, Hôpital Saint-Louis, 1, avenue Claude Vellefaux, F-75010, Paris, France. E-mail address: nicolas.dulphy{at}univ-paris-diderot.fr
4 Abbreviations used in this paper: HSCT, hematopoietic stem cell transplantation; ADCC, antibody-dependent cellular cytotoxicity; aGVHD, acute GVHD; GVHD, graft-vs-host disease; GVL, graft vs leukemia; KIR, killer immunoglobulin-like receptor; MICA/B, MHC class I-related molecules A and B; NCR, natural cytotoxicity receptor; ULBP, UL16-binding protein.
This article has been cited by other articles:
![]() |
J. L. Espinoza, A. Takami, M. Onizuka, H. Sao, H. Akiyama, K. Miyamura, S. Okamoto, M. Inoue, Y. Kanda, S. Ohtake, et al. NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies Haematologica, October 1, 2009; 94(10): 1427 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, J. M. Venstrom, X.-R. Liu, J. Pring, R. S. Hasan, R. J. O'Reilly, and K. C. Hsu Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation Blood, April 16, 2009; 113(16): 3875 - 3884. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |